Showing results (111-120 of 130) with videos related to

Sort By:
Pageof 13
Advances in Chronic Kidney Disease|October 20, 2004
Effect of predialysis eating on measurement of urea reduction ratio and Kt/VNaveen Singri, Duncan Johnstone, James Paparello, et al.
Plos One|January 9, 2014
Effect of insulin on ACE2 activity and kidney function in the non-obese diabetic mouseMarta Riera, Eva Márquez, Sergi Clotet, et al.
Anticancer Research|May 31, 2015
Cellular Vaccines Modified with Hyper IL6 or Hyper IL11 Combined with Docetaxel in an Orthotopic Prostate Cancer ModelJacek Mackiewicz, Urszula Kazimierczak, Marek Kotlarski, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 25, 2006
Paricalcitol capsule for the treatment of secondary hyperparathyroidism in stages 3 and 4 CKDDaniel Coyne, Muralidhar Acharya, Ping Qiu, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 11, 2014
Improving CKD therapies and care: a National DialogueFrederick Kaskel, Daniel Batlle, Srinivasan Beddhu, et al.
The Journal of Pathology|September 17, 2013
TWEAK transactivation of the epidermal growth factor receptor mediates renal inflammationSandra Rayego-Mateos, Jose Luis Morgado-Pascual, Ana Belen Sanz, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 21, 2022
Spherical nucleic acids as an infectious disease vaccine platformMichelle H Teplensky, Max E Distler, Caroline D Kusmierz, et al.
American Journal of Nephrology|March 18, 2006
A comparison of dosing regimens of paricalcitol capsule for the treatment of secondary hyperparathyroidism in CKD stages 3 and 4Hanna Abboud, Daniel Coyne, Olgierd Smolenski, et al.
Journal of Molecular Cell Biology|March 13, 2020
Cyclophilins A and B oppositely regulate renal tubular epithelial cell phenotypeEduard Sarró, Mónica Durán, Ana Rico, et al.
Pageof 13